These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 26254990)
21. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity. Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406 [TBL] [Abstract][Full Text] [Related]
22. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
23. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation. Kim S; Lim JH; Woo CH Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924 [TBL] [Abstract][Full Text] [Related]
24. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells. Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661 [TBL] [Abstract][Full Text] [Related]
25. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression. Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231 [TBL] [Abstract][Full Text] [Related]
26. PM Xu Z; Li Z; Liao Z; Gao S; Hua L; Ye X; Wang Y; Jiang S; Wang N; Zhou D; Deng X Ecotoxicol Environ Saf; 2019 Apr; 171():112-121. PubMed ID: 30597315 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2. Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840 [TBL] [Abstract][Full Text] [Related]
28. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment]. Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559 [TBL] [Abstract][Full Text] [Related]
29. Notch induces myofibroblast differentiation of alveolar epithelial cells via transforming growth factor-{beta}-Smad3 pathway. Aoyagi-Ikeda K; Maeno T; Matsui H; Ueno M; Hara K; Aoki Y; Aoki F; Shimizu T; Doi H; Kawai-Kowase K; Iso T; Suga T; Arai M; Kurabayashi M Am J Respir Cell Mol Biol; 2011 Jul; 45(1):136-44. PubMed ID: 21749980 [TBL] [Abstract][Full Text] [Related]
30. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178 [TBL] [Abstract][Full Text] [Related]
31. Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells. Fang LP; Lin Q; Tang CS; Liu XM Pharmacol Res; 2010 Apr; 61(4):298-305. PubMed ID: 19913099 [TBL] [Abstract][Full Text] [Related]
32. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
33. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice. Shen M; Liu X; Zhang H; Guo SW Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216 [TBL] [Abstract][Full Text] [Related]
37. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice. Jin M; Wu Y; Wang L; Zang B; Tan L Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519 [TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196 [TBL] [Abstract][Full Text] [Related]
39. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway. Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition. Han Q; Lin L; Zhao B; Wang N; Liu X Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]